<?php
include_once('../../includes/inc.php');

htmlHeader(array("title"=>"Publications","metaDesc"=>"Resolution Bioscience Publications"));
?>
<div class="main-container">
<section class="page-title page-title-3 image-bg overlay parallax">
    <div class="background-image-holder">
        <img alt="Background Image" class="background-image" src="/img/news.jpg">
    </div>
<div class="container">
    <div class="row">
        <div class="col-sm-12 text-center">
            <h3 class="uppercase mb0">Publications &amp; Presentations</h3>
        </div>
    </div>
</div>
</section>
<section>
    <div class="container">
        <div class="row">
            <div class="col-md-10 col-sm-10 col-md-push-1 col-sm-push-2 boxed-light pt16 pb0"><h5><a href="http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176241" target="_new">PLOS: Collection of cell-free DNA for genomic analysis of solid tumors in a clinical laboratory setting</a></h5><a class="btn btnLink" href="http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176241" target="_new">Read more</a><br><img src="/img/PLOS-ResolutionBio-cfDNA.png" width="50%"></a>
            </div>
        </div>
        <div class="row">
            <div class="col-md-10 col-sm-10 col-md-push-1 col-sm-push-2 boxed-light pt16 pb0"><h5><a href="http://www.abstractsonline.com/pp8/#!/4292/presentation/1329" target="_new">Longitudinal monitoring of cell-free DNA in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse</a></h5><a href="http://www.abstractsonline.com/pp8/#!/4292/presentation/1329" target="_new">
				<a class="btn btnLink" href="http://www.abstractsonline.com/pp8/#!/4292/presentation/1329" target="_new">Read more</a><br><img src="/img/AACR2017.jpg"></a>
            </div>
        </div>
        <div class="row">
            <div class="col-md-10 col-sm-10 col-md-push-1 col-sm-push-2 boxed-light pt16 pb0"><h5><a href="/publications/ResolutionBio_ESMO2016.pdf" target="_new">Utility of a targeted NGS oncology assay for circulating tumor DNA in a multi-histology clinical setting</a></h5><a href="/publications/ResolutionBio_ESMO2016.pdf" target="_new"><img src="/img/ESMO-2016-Poster.jpg"></a>
            </div>
        </div>
        <div class="row">
            <div class="col-md-10 col-sm-10 col-md-push-1 col-sm-push-2 boxed-light pt16 pb0">                                                        <h5><a href="/publications/ResolutionBio_Ensartinib_ESMO2016.pdf" target="_new">Phase I/II trial of ensartinib+ (X-396) in patients with ALK+ non-small cell lung cancer (NSCLC): Correlation with plasma and tissue genotyping and response to therapy</a></h5><a href="/publications/ResolutionBio_Ensartinib_ESMO2016.pdf" target="_new"><img src="/img/ResolutionBio_Ensartinib_ESMO2016.jpg"></a>
            </div>
        </div>
        <div class="row">
            <div class="col-md-10 col-sm-10 col-md-push-1 col-sm-push-2 boxed-light pt16 pb0">
                <h5><a href="/publications/ResolutionBio_Ensartinib_ASCO2016.pdf" target="_new">Plasma genotyping of patients in the eXalt2 trial: ensartinib+ (X-396) in ALK+ non-small cell lung cancer (NSCLC)</a></h5><a href="/publications/ResolutionBio_Ensartinib_ASCO2016.pdf" target="_new"><img src="/img/ResolutionBio_Ensartinib_ASCO2016.jpg"></a>
            </div>
        </div>
        <div class="row">
            <div class="col-md-10 col-sm-10 col-md-push-1 col-sm-push-2 boxed-light pt16 pb0">
                <h5><a href="http://clincancerres.aacrjournals.org/content/early/2015/10/10/1078-0432.CCR-15-1627-T.abstract?papetoc" target="_new">Bias-corrected targeted next-generation sequencing for rapid, multiplexed detection of actionable alterations in cell-free DNA from advanced lung cancer patients</a></h5>
							<p>
Purpose: Tumor genotyping is a powerful tool for guiding non-small cell lung cancer (NSCLC) care, however comprehensive tumor genotyping can be logistically cumbersome. To facilitate genotyping, we developed a next-generation sequencing (NGS) assay using a desktop sequencer to detect actionable mutations and rearrangements in cell-free plasma DNA (cfDNA). Experimental Design: An NGS panel was developed targeting 11 NSCLC driver oncogenes. Targeted NGS was performed using a novel methodology that maximizes on-target reads, and minimizes artifact, and validated on DNA dilutions derived from cell lines. Plasma NGS was then blindly performed on 48 patients with advanced, progressive NSCLC and a known genotype, and explored in two patients with incomplete tumor genotyping. Results: NGS could identify mutations present in DNA dilutions at ≥0.4% allelic frequency with 100% sensitivity/specificity. Plasma NGS detected a broad range of driver and resistance mutations, including ALK rearrangements, HER2 insertions, and MET amplification, with 100% specificity. Sensitivity was 77% across 62 known driver and resistance mutations from the 48 cases; in 29 cases with common EGFR and KRAS mutations, sensitivity was similar to droplet digital PCR. In two cases with incomplete tumor genotyping, plasma NGS rapidly identified a novel EGFR exon 19 deletion and a missed case of MET amplification. Conclusion: Blinded to tumor genotype, this plasma NGS approach detected targetable genomic alterations in NSCLC with no false positives. Through use of widely available vacutainers and a desktop sequencing platform, this assay has the potential to be implemented broadly for patient care and translational research.</p>
			<a class="btn mb0" href="http://clincancerres.aacrjournals.org/content/early/2015/10/10/1078-0432.CCR-15-1627-T.abstract?papetoc" target="_new">Read More</a>
						</div>
					</div>
					<div class="row">
					<div class="citation boxed-light col-md-10 col-sm-10 col-md-push-1 col-sm-push-1 pt16 pb16">
<a href="http://clincancerres.aacrjournals.org/content/early/2015/10/10/1078-0432.CCR-15-1627-T.abstract?papetoc" target="_new">Paweletz et al. Bias-corrected targeted next-generation sequencing for rapid, multiplexed detection of actionable alterations in cell-free DNA from advanced lung cancer patients</a> &mdash; <a href="http://clincancerres.aacrjournals.org/content/early/2015/10/10/1078-0432.CCR-15-1627-T.abstract?papetoc" target="_new">Clinical Cancer Research</a>
</div>
					</div>	
				</div>
				
			</section>
</div>
<?php
footer();
?>
